Literature DB >> 31103235

Omecamtiv Mecarbil Slows Myosin Kinetics in Skinned Rat Myocardium at Physiological Temperature.

Thinh T Kieu1, Peter O Awinda1, Bertrand C W Tanner2.   

Abstract

Heart failure is a life-threatening condition that occurs when the heart muscle becomes weakened and cannot adequately circulate blood and nutrients around the body. Omecamtiv mecarbil (OM) is a compound that has been developed to treat systolic heart failure via targeting the cardiac myosin heavy chain to increase myocardial contractility. Biophysical and biochemical studies have found that OM increases calcium (Ca2+) sensitivity of contraction by prolonging the myosin working stroke and increasing the actin-myosin cross-bridge duty ratio. Most in vitro studies probing the effects of OM on cross-bridge kinetics and muscle force production have been conducted at subphysiological temperature, even though temperature plays a critical role in enzyme activity and cross-bridge function. Herein, we used skinned, ventricular papillary muscle strips from rats to investigate the effects of [OM] on Ca2+-activated force production, cross-bridge kinetics, and myocardial viscoelasticity at physiological temperature (37°C). We find that OM only increases myocardial contractility at submaximal Ca2+ activation levels and not maximal Ca2+ activation levels. As [OM] increased, the kinetic rate constants for cross-bridge recruitment and detachment slowed for both submaximal and maximal Ca2+-activated conditions. These findings support a mechanism by which OM increases cardiac contractility at physiological temperature via increasing cross-bridge contributions to thin-filament activation as cross-bridge kinetics slow and the duration of cross-bridge attachment increases. Thus, force only increases at submaximal Ca2+ activation due to cooperative recruitment of neighboring cross-bridges, because thin-filament activation is not already saturated. In contrast, OM does not increase myocardial force production for maximal Ca2+-activated conditions at physiological temperature because cooperative activation of thin filaments may already be saturated.
Copyright © 2019 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31103235      PMCID: PMC6554472          DOI: 10.1016/j.bpj.2019.04.020

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  80 in total

Review 1.  Regulation of contraction in striated muscle.

Authors:  A M Gordon; E Homsher; M Regnier
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

2.  Myofilament properties comprise the rate-limiting step for cardiac relaxation at body temperature in the rat.

Authors:  Paul M L Janssen; Linda B Stull; Eduardo Marbán
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-02       Impact factor: 4.733

3.  Modeling thin filament cooperativity.

Authors:  M A Geeves; S S Lehrer
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

4.  Relaxation kinetics following sudden Ca(2+) reduction in single myofibrils from skeletal muscle.

Authors:  Chiara Tesi; Nicoletta Piroddi; Francesco Colomo; Corrado Poggesi
Journal:  Biophys J       Date:  2002-10       Impact factor: 4.033

5.  Muscle structure and theories of contraction.

Authors:  A F HUXLEY
Journal:  Prog Biophys Biophys Chem       Date:  1957

6.  Interpreting cardiac muscle force-length dynamics using a novel functional model.

Authors:  Kenneth B Campbell; Murali Chandra; Robert D Kirkpatrick; Bryan K Slinker; William C Hunter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-04       Impact factor: 4.733

7.  Mutations of hydrophobic residues in the N-terminal domain of troponin C affect calcium binding and exchange with the troponin C-troponin I96-148 complex and muscle force production.

Authors:  Jonathan P Davis; Jack A Rall; Catalina Alionte; Svetlana B Tikunova
Journal:  J Biol Chem       Date:  2004-02-16       Impact factor: 5.157

8.  Effect of dimethyl sulfoxide on excitation-contraction coupling in chicken slow skeletal muscle.

Authors:  Raymundo Velasco; Xóchitl Trujillo; Clemente Vásquez; Miguel Huerta; Benjamín Trujillo-Hernández
Journal:  J Pharmacol Sci       Date:  2003-10       Impact factor: 3.337

9.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

Authors:  Margaret M Redfield; Steven J Jacobsen; John C Burnett; Douglas W Mahoney; Kent R Bailey; Richard J Rodeheffer
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

10.  Interplay of troponin- and Myosin-based pathways of calcium activation in skeletal and cardiac muscle: the use of W7 as an inhibitor of thin filament activation.

Authors:  Bishow B Adhikari; Kuan Wang
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

View more
  6 in total

1.  Mavacamten decreases maximal force and Ca2+ sensitivity in the N47K-myosin regulatory light chain mouse model of hypertrophic cardiomyopathy.

Authors:  Peter O Awinda; Marissa Watanabe; Yemeserach Bishaw; Anna M Huckabee; Keinan B Agonias; Katarzyna Kazmierczak; Danuta Szczesna-Cordary; Bertrand C W Tanner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-12-18       Impact factor: 4.733

2.  Orthophosphate increases the efficiency of slow muscle-myosin isoform in the presence of omecamtiv mecarbil.

Authors:  Serena Governali; Marco Caremani; Cristina Gallart; Irene Pertici; Ger Stienen; Gabriella Piazzesi; Coen Ottenheijm; Vincenzo Lombardi; Marco Linari
Journal:  Nat Commun       Date:  2020-07-07       Impact factor: 14.919

3.  Generative adversarial networks for construction of virtual populations of mechanistic models: simulations to study Omecamtiv Mecarbil action.

Authors:  Jaimit Parikh; Timothy Rumbell; Xenia Butova; Tatiana Myachina; Jorge Corral Acero; Svyatoslav Khamzin; Olga Solovyova; James Kozloski; Anastasia Khokhlova; Viatcheslav Gurev
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-10-29       Impact factor: 2.745

4.  Effects of omecamtiv mecarbil on the contractile properties of skinned porcine left atrial and ventricular muscles.

Authors:  Tomohiro Nakanishi; Kotaro Oyama; Hiroyuki Tanaka; Fuyu Kobirumaki-Shimozawa; Shuya Ishii; Takako Terui; Shin'ichi Ishiwata; Norio Fukuda
Journal:  Front Physiol       Date:  2022-08-23       Impact factor: 4.755

5.  Quantitative mapping of force-pCa curves to whole-heart contraction and relaxation.

Authors:  Stefano Longobardi; Anna Sher; Steven A Niederer
Journal:  J Physiol       Date:  2022-07-17       Impact factor: 6.228

6.  Myocardial Contractility: Historical and Contemporary Considerations.

Authors:  William W Muir; Robert L Hamlin
Journal:  Front Physiol       Date:  2020-03-31       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.